• Non ci sono risultati.

Rischi di bias negli studi clinici

N/A
N/A
Protected

Academic year: 2022

Condividi "Rischi di bias negli studi clinici"

Copied!
22
0
0

Testo completo

(1)

Percorso di Formazione Linee Guida AIOM

Milano 1-2 febbraio 2018

Rischi di bias negli studi clinici

Giovanni Pappagallo

(2)

ERRORE CASUALE

Errore che si verifica per effetto del caso

• Replicazioni multiple della stessa misurazione producono differenti risultati in tutte le direzioni per variazioni casuali ma la media fornisce il risultato corretto

ERRORE SISTEMATICO

Errore che si verifica per la presenza di un fattore che distorce sistematicamente le osservazioni nella stessa direzione

• Replicazioni multiple della stessa misurazione producono risultati sempre nella stessa direzione, ma

“erronei”

(3)
(4)

Population

Treatment Comparator

Outcome assessment

Outcome assessment

Selection Bias

Performance Bias Detection Bias

Attrition Bias

Study Flow & Risk of Bias…

Publication Reporting Bias

(5)

SOURCES OF BIAS IN CLINICAL TRIALS

(6)

Item Descriptor

Sequence generation

Method used to generate the random allocation sequence, including details of any restriction (eg, blocking, stratification)

Allocation concealment

Method used to implement the random allocation sequence (eg, numbered containers or central telephone), clarifying whether the sequence was concealed until interventions were assigned

Implementation

Who generated the allocation sequence, who

enrolled participants, and who assigned participants to their groups

RANDOMIZATION COMPONENTS

(7)

Schulz. The Lancet Volume:

359 Issue 9306 (2002)

Allocation

concealment in randomised

trials:defending against

deciphering.

(8)

Any observed difference between the outcomes of study arms may be

attributable to baseline differences rather than to a true treatment effect.

(9)
(10)
(11)

SOURCES OF BIAS IN CLINICAL TRIALS

(12)

If no patient blinding was performed…

… were they unbiased when filling the QoL questionnaire?

(13)

SOURCES OF BIAS IN CLINICAL TRIALS

(14)

If no evaluator blinding was performed…

… was he (totally) unbiased when evaluating the scan?

(15)

Allocation

Concealment Blinding

• It prevents selection bias in intervention assignment by protecting the allocat- ion sequence before and until assignment

• It can always be success- fully implemented regard- less of the study topic

• It seeks to prevent perform- ance and detection bias by protecting the sequence after assignment

• Not always feasible – for

example, in trials comparing surgical with medical interv- entions

WARNING!

(16)

SOURCES OF BIAS IN CLINICAL TRIALS

(17)

A ciascuno studio è richiesto di dare conto del flusso di pazienti

nelle fasi di arruolamento, assegnazione del trattamento,

follow-up e analisi

(18)
(19)

SOURCES OF BIAS IN CLINICAL TRIALS

(20)

Primary endpoint not met

Outcome reporting bias

(21)
(22)

Riferimenti

Documenti correlati